Diplomat to Participate in Bank of America Merrill Lynch 2017 Healthcare Conference
FLINT, Mich. — May 3, 2017 — Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation’s largest independent specialty pharmacy, has announced that Phil Hagerman, CEO and chairman, will present at the upcoming Bank of America Merrill Lynch 2017 Healthcare Conference in Las Vegas, NV.
Mr. Hagerman is scheduled to present at the conference on Tuesday, May 16, 2017, at 4:20 p.m. P.T. A live audio-only webcast of the presentation and related presentation materials will be available on the investor relations section of the Company’s website at ir.diplomat.is. The archived webcast and presentation materials will also be available for approximately 90 days at the same URL.
Diplomat (NYSE: DPLO) serves patients and physicians in all 50 states. Headquartered in Flint, Michigan, the company focuses on medication management programs for people with complex chronic diseases. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: “Take good care of patients and the rest falls into place.” Today, that tradition continues—always focused on improving patient care and clinical adherence. For more information, visit diplomat.is.
Bob East, Westwicke Partners
443.213.0500 | email@example.com
Jenny Cretu, Diplomat
810.768.9370 | firstname.lastname@example.org
@BusLeadersforMIRT @BusLeadersforMI: Hear from Mike Miller, Director of @Google Tech Services & Phil Hagerman, CEO of @DiplomatRx at 11/9 #MICEOSummit! htt…8 hours ago
@SpecialtyPTimesRT @SpecialtyPTimes: Happy #WorldPharmacistDay to our wonderful followers who make a difference in patient lives every day! How are you cel…11 hours ago
@DiplomatRx@BuntyLUFC We appreciate you reaching out. Would you mind direct messaging us so we can help?5 days ago
@DiplomatRxOur Navigating Patient Engagement webinar is available on demand. Sign up at https://t.co/LN1qWkrCZp to watch the r… https://t.co/RaQGhk3xF75 days ago
@SpecialtyPharmRT @SpecialtyPharm: Specialty Pharmacies Earn High Marks in First NASP Patient Satisfaction @Rx_Specialty Survey #NASP2017 https://t.co/B0k…5 days ago